Mettler-Toledo International (NYSE:MTD) Earns Peer Perform Rating from Analysts at Wolfe Research

Wolfe Research assumed coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research note issued to investors on Friday. The brokerage set a “peer perform” rating on the medical instruments supplier’s stock.

A number of other equities research analysts also recently weighed in on MTD. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday. Wells Fargo & Company reduced their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Trading Down 0.9 %

Mettler-Toledo International stock traded down $11.42 during trading hours on Friday, reaching $1,265.50. 47,618 shares of the company were exchanged, compared to its average volume of 135,201. Mettler-Toledo International has a 12 month low of $1,115.64 and a 12 month high of $1,546.93. The firm has a market cap of $26.70 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 4.19 and a beta of 1.13. The stock has a 50-day moving average of $1,309.36 and a 200 day moving average of $1,378.81.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. As a group, research analysts forecast that Mettler-Toledo International will post 40.42 EPS for the current year.

Insiders Place Their Bets

In related news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now directly owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gerry Keller sold 140 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. UMB Bank n.a. increased its position in shares of Mettler-Toledo International by 6.6% in the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after acquiring an additional 7 shares during the last quarter. DT Investment Partners LLC lifted its stake in Mettler-Toledo International by 13.3% in the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after purchasing an additional 8 shares during the last quarter. Suncoast Equity Management grew its holdings in Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after purchasing an additional 9 shares during the period. Bleakley Financial Group LLC increased its position in Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock worth $1,135,000 after buying an additional 9 shares during the last quarter. Finally, Huntington National Bank raised its stake in Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.